Carbapenem-resistant enterobacteriaceae (CRE)

Carbapenem-resistant enterobacteriaceae (CRE) is a topic covered in the Guide to Diagnostic Tests.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --

Organism

Carbapenem-resistant enterobacteriaceae (CRE)

Carbapenemase production in the Enterobacteriaceae was unknown until early 2000s. Almost all carbapenem-resistant isolates were sporadic cases of hyperproduction of a beta-lactamase (AmpC or ESBL) combined with porin loss.

In 2001, there was the first report of carbapenem-resistant Klebsiella pneumoniae ; it carried a new carbapenemase, KPC enzyme.

New Delhi metallo-beta-lactamase (NDM1) has been described in patients infected with Escherichia coli or Klebsiella pneumoniae during surgery in India and Pakistan.

Outbreaks have been seen worldwide since 2003 of OXA-48 carbapenemase in K. pneumoniae , resulting in resistance to all beta-lactams.

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Carbapenem-resistant enterobacteriaceae (CRE) ID - 619589 A1 - Lu,Chuanyi Mark, AU - McPhee,Stephen J, AU - Nicoll,Diana, BT - Guide to Diagnostic Tests UR - https://im.unboundmedicine.com/medicine/view/GDT/619589/all/Carbapenem_resistant_enterobacteriaceae__CRE_ PB - McGraw-Hill Education ET - 7 DB - Medicine Central DP - Unbound Medicine ER -